tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Financial Statements

Compare
1 Followers

Keymed Biosciences, Inc. Financial Overview

Keymed Biosciences, Inc.'s market cap is currently HK$16.44B. The company's EPS TTM is HK$-0.327949137; its P/E ratio is -57.23; Keymed Biosciences, Inc. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 428.12M¥ 354.10M¥ 100.06M¥ 110.27M¥ 0.00
Gross Profit¥ 415.92M¥ 317.22M¥ 97.48M¥ 93.07M¥ 0.00
Operating Income¥ -618.10M¥ -434.80M¥ -543.81M¥ -3.88B¥ -148.95M
EBITDA¥ -574.46M¥ -269.77M¥ -259.25M¥ -3.86B¥ -135.09M
Net Income¥ -515.24M¥ -359.36M¥ -308.12M¥ -3.90B¥ -832.73M
Balance Sheet
Cash & Short-Term Investments¥ 2.16B¥ 2.72B¥ 3.18B¥ 3.52B¥ 354.08M
Total Assets¥ 3.77B¥ 3.88B¥ 3.93B¥ 3.93B¥ 529.95M
Total Debt¥ 753.24M¥ 418.71M¥ 121.97M¥ 39.26M¥ 66.86M
Net Debt¥ 334.82M¥ -432.32M¥ -482.10M¥ -1.48B¥ -132.54M
Total Liabilities¥ 1.29B¥ 896.11M¥ 593.10M¥ 289.07M¥ 1.62B
Stockholders' Equity¥ 2.47B¥ 2.99B¥ 3.34B¥ 3.65B¥ -1.09B
Cash Flow
Free Cash Flow¥ -1.00B¥ -686.23M¥ -681.48M¥ -387.50M¥ -139.26M
Operating Cash Flow¥ -789.63M¥ -303.62M¥ -401.93M¥ -214.64M¥ -119.36M
Investing Cash Flow¥ 67.71M¥ 468.20M¥ -645.59M¥ -2.04B¥ -113.07M
Financing Cash Flow¥ 283.90M¥ 72.13M¥ -8.06M¥ 3.64B¥ 7.40M
Currency in CNY

Keymed Biosciences, Inc. Earnings and Revenue History

Keymed Biosciences, Inc. Debt to Assets

Keymed Biosciences, Inc. Cash Flow

Keymed Biosciences, Inc. Forecast EPS vs Actual EPS